| 000 | 01648 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517014545.0 | ||
| 264 | 0 | _c20151117 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a1499-3872 | ||
| 024 | 7 |
_a10.1016/s1499-3872(14)60290-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYong, Feng-Jiao | |
| 245 | 0 | 0 |
_aContinuous regional arterial infusion for the treatment of severe acute pancreatitis: a meta-analysis. _h[electronic resource] |
| 260 |
_bHepatobiliary & pancreatic diseases international : HBPD INT _cFeb 2015 |
||
| 300 |
_a10-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCardiovascular Agents |
| 650 | 0 | 4 |
_aCatheterization, Peripheral _xadverse effects |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intra-Arterial |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aPancreatitis _xcomplications |
| 650 | 0 | 4 |
_aProtease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMao, Xuan-Yue | |
| 700 | 1 | _aDeng, Li-Hui | |
| 700 | 1 | _aZhang, Ming-Ming | |
| 700 | 1 | _aXia, Qing | |
| 773 | 0 |
_tHepatobiliary & pancreatic diseases international : HBPD INT _gvol. 14 _gno. 1 _gp. 10-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1499-3872(14)60290-3 _zAvailable from publisher's website |
| 999 |
_c24597980 _d24597980 |
||